Mark H. Smith’s daughter, Mallory, died at 25 from a bacterial infection after a double-lung transplant. They tried phage therapy, which showed promise but was too late. Antimicrobial resistance is a global health threat, with bacteria resistant to antibiotics. Phage therapy, using viruses to target bacteria, has advantages over antibiotics. However, FDA regulations limit its use in the U.S. Loosening regulations and promoting research into phage therapy could save lives. Mallory’s story and advocacy aim to raise awareness about antimicrobial resistance. The FDA must adapt to allow innovative treatments. The potential benefits of phage therapy outweigh the risks in the fight against drug-resistant infections.
Source link
Bacteriophage therapy could counter rise in antimicrobial resistance
